Alfredo Addeo

InstitutionUniversity Hospital of Geneva
AddressGeneva
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in May 2020
    All Publications
    Bar chart showing 58 publications over 15 distinct years, with a maximum of 14 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Banna GL, Cantale O, Friedlaender A, Yusof H, Acharige S, Alfredo A. Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy. Cancer Invest. 2021 Aug 19; 1-12. PMID: 34409906.
      Citations:    Fields:    
    2. Addeo A, Shah PK, Bordry N, Hudson RD, Albracht B, Di Marco M, Kaklamani V, Dietrich PY, Taylor BS, Simand PF, Patel D, Wang J, Labidi-Galy I, Fertani S, Leach RJ, Sandoval J, Mesa R, Lathrop K, Mach N, Shah DP. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. Cancer Cell. 2021 08 09; 39(8):1091-1098.e2. PMID: 34214473.
      Citations: 30     Fields:    Translation:Humans
    3. Sandoval JL, Friedlaender A, Addeo A. Is clinical effectiveness in the eye of the beholder during the COVID-19 pandemic? BMJ Evid Based Med. 2021 12; 26(6):307-308. PMID: 32647067.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev. 2020 Aug; 88:102041. PMID: 32516704.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    5. Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, Dziadziuszko R, de Marinis F, Reck M, Bouchaab H, Peters S. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 2020 06; 5(Suppl 3). PMID: 32581069.
      Citations: 28     Translation:HumansCellsPHPublic Health
    6. Friedlaender A, Kim C, Addeo A. Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic. Front Oncol. 2020; 10:862. PMID: 32574277.
      Citations: 5     
    7. Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. Reply to Authors. ESMO Open. 2020 05; 4(Suppl 2):e000809. PMID: 32409299.
      Citations:    Translation:HumansCellsPHPublic Health
    8. Addeo A, Obeid M, Friedlaender A. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. J Immunother Cancer. 2020 05; 8(1). PMID: 32434788.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    9. Banna G, Curioni-Fontecedro A, Friedlaender A, Addeo A. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. ESMO Open. 2020 04; 5(2):e000765. PMID: 32245904.
      Citations: 47     Translation:HumansPHPublic Health